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Abstract
BACKGROUND: The aim of our study was to evaluate the role
of myocardial perfusion imaging (MPI) and common carotid
artery intima-media thickness (CCA IMT) in the prognosis
of patients with coronary artery disease referred for coronary ar-
tery bypass surgery (CABG) in a newly made prognostic model.
MATERIAL AND METHODS: 63 patients (age 60.36 – 8.28
years) with angiographically established coronary artery dis-
ease referred for CABG were evaluated for: age, smoking, fam-
ily disposition, dyslipidaemia, arterial hypertension, obesity,
diabetes mellitus, previous myocardial infarction and revascu-
larization. Patients underwent nitrate enhanced Gated SPECT
myocardial perfusion imaging, with 17-segment analysis for cal-
culation of perfusion scores and viability index. Common carotid
artery IMT was measured by B-mode ultrasound. Patients were
followed for cardiovascular events 12 months after CABG.
RESULTS: The obtained data reported mean values of left ven-
tricular ejection fraction (LVEF) 46.2 – 14.4%, viability index
0.76 – 0.55, SRS 17.76 – 13.81 and summed nitrate score
12.89 – 10.36. Ultrasound detected CCA IMT 0.90 – 0.24 mm,
with increased value in 67.2% and presence of carotid plaques
in 27.1% of pts. We registered 14 events and 8.8% mortality rate.
Multiple regression modelling showed bilateral carotid plaque
presence as a predictor of total events. Viability index and CCA
IMT have been found as independent death predictors.
CONCLUSIONS: Myocardial perfusion viability index and CCA
IMT are predictors, independently associated with prognosis
of patients referred for CABG.
Key words: myocardial viability, intima-media thickness,
carotid plaque, coronary artery bypass surgery, prognosis
Introduction
The changing profile of patients undergoing coronary surgery
operations necessitates continuous updating and revision of risk
models. Investigation of the prognostic importance of the extent
of viable myocardium may help determine which patients derive
the greatest survival benefit from revascularization [1, 2]. Preop-
erative myocardial perfusion imaging and subsequent coronary
revascularization for high-risk patients improve perioperative and
long-term outcome. The detection of viable myocardium has be-
come of great clinical importance, due to the major prognostic
role and therapeutic implications of myocardial viability [5].
Measurements of carotid IMT may be used to identify high-
-risk patients with coronary artery disease. Carotid IMT has been
shown as a powerful predictor of cardiovascular events in pa-
tients with proven coronary artery disease and cardiovascular di-
sease [6, 7]. Intima-media tickness correlates with coronary artery
disease, proven angiographically, but not with myocardial scin-
tigraphy [8, 9]. Studies made by Lacroix and Reed refer to the
predictive role of increased IMT in clinical outcomes in patients
with coronary artery disease after revascularization [10, 11]. Some
studies could not find IMT as a predictor of coronary artery di-
sease, or found it only as a predictor of stroke, and less clearly
associated with coronary events. It is indicated that carotid plaques
are closely associated with coronary artery disease prognosis [12
14]. The occurrence of carotid plaques are a good surrogate for
predicting coronary artery disease, expressed as myocardial
hypoperfusion by myocardial scintigraphy [9].
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A predictive model for coronary artery bypass patients that
includes both methods: myocardial perfusion findings and carot-
id ultrasound, has not been studied yet.
The aim of this study was to identify preoperative determi-
nants that influence postoperative cardiovascular events in pa-
tients with coronary artery disease, who underwent primary
isolated CABG. We especially wanted to investigate whether
the presence and extent of viable myocardium, values of ejec-
tion fraction and extent of non viable tissue influence long-
term prognosis in revascularized patients. We also sought
to study whether there is an additional role of carotid ultra-
sound in the prognosis of coronary artery bypass patients,
when added to myocardial Gated SPECT imaging findings and
traditional risk factors.
Material and methods
Study population
Between January and December 2004, 63 consecutive
patients with mean age 60.36 – 8.28 years, referred for CABG, were
studied at our institute. Preoperative ejection fraction of 46 – 14%
was verified with Gated SPECT imaging. Patients undergoing com-
bined procedures as CABG with valvular surgery, angioplasty,
aortic or carotid surgery were excluded from the study, as well as
patients undergoing urgent surgery and patients with renal fail-
ure. Preoperative and postoperative angina and dyspnoea were
assessed according to the Canadian Cardiovascular Society (CCS)
and the New York Heart Association (NYHA) functional classifica-
tion. Major clinical indications for surgery were dominating angina
pectoris in 45 patients (71%) and dyspnoea in 15 patients (24%).
Thirty-four patients (54%) had severe CCS angina and 25 patients
(40%) had II/III NYHA functional class preoperatively. The deci-
sion to perform CABG was based on clinical and angiographic
criteria according to the recommendations of ACC/AHA coronary
artery bypass surgery guidelines. All patients gave informed con-
sent as part of the protocol approved by the Ethical Committee
on Human Studies at our University.
Study protocol
All patients were evaluated for the following preoperative
parameters: age, sex, smoking, family disposition, presence of dys-
lipidaemia, arterial hypertension, obesity, diabetes mellitus, previ-
ous myocardial infarction and coronary revascularization. All pa-
tients underwent coronary angiography before MPI. Coronary
stenosis equal to or greater than 70% of luminal diameter was
considered significant. Left main coronary artery disease was re-
ported in the presence of stenosis equal to or greater than 50%
of luminal diameter. Gensini angiographic score was calculated
for all patients. Left ventricular ejection fraction with Tc-99m-Ses-
tamibi myocardial Gated-SPECT was evaluated before CABG. Pre-
operative myocardial viability and carotid ultrasound imaging with
CCA intima-media thickness (IMT) were assessed in all patients.
CCA IMT was measured by B-mode ultrasound using a tomo-
graphic ultrasound system (HP Agilent S 4500) with a linear trans-
ducer (7.510 MHz) and presented as mean value of three mea-
surements from both sides. Carotid stenosis (CS) ‡ 60% was
considered significant. Carotid IMT was defined as the distance
from the leading edge of the first echogenic line to the leading
edge of the second echogenic line on the scans, with the first line
representing the lumen-intimal interface and the second line rep-
resenting the collagen-containing upper layer of the adventitia.
IMT with value equal to or great than 0.8 mm were defined
as increased IMT. Plaque was defined as a localized thickening
lesion (‡ 1.1 mm). In each longitudinal projection, the site with
the greatest thickness (including plaque) was detected along the
vessel from the common carotid artery to the internal carotid artery.
Primary indication for the MPI was evaluation of myocardial
viability before CABG. Patients underwent one day rest-nitrate
enhanced gated SPECT Tc-99m-Sestamibi protocol with 370/925
MBq, after sublingual application of 0.5 mg nitro-glycerine (NTG).
Haemodynamic response to the nitrate was monitored in all pa-
tients. Image acquisition was performed 6090minutes after in-
jection of Tc-99m-Sestamibi using a single headed Sopha Medi-
cal Vision DS7 SPECT gamma camera. Attenuation correction was
not used. For quantitative analysis of myocardial perfusion, a com-
mercial program for Bulls eye analysis was used. The MultiDim
program was included in the software of the gamma camera for
assessment of left ventricular function. Image interpretation was
done using a 17-segment model and 5-point scoring system
to assess perfusion (0  normal perfusion; 1  mild hypoperfu-
sion; 2  moderate; 3  severe hypoperfusion: and 4  absent
uptake). A segment was predetermined to be viable if the perfu-
sion segment score was £ 2 and wall thickening was present.
A 5-point scoring system was used to assess wall motion: 0  nor-
mal, 1  moderate, 2  severe hypokinesia, 3  akinesia and
4  dyskinesia. A segment was predetermined to be viable by
function if the segment score was £ 2  (2  normal perfusion,
1  moderate-severe hypoperfusion; 0  absent uptake). A via-
bility index (VI) was calculated as value of the Tc-99m-Sestamibi
uptake in each segment, divided by the total number of segments
evaluated. A viability index > 0.5 was considered as an indication
of a significant degree of viable myocardium. The following crite-
ria for myocardial viability were used: 1. Tc-99m-Sestamibi res-
ting uptake >50%; 2. nitrate-induced uptake increase > 10% and
nitrate activity ‡ 65%, with resting wall motion abnormality (scores
24). The segment target for revascularization were judged either
completely viable, partially or totally scared. Summed nitrate score
(SNS), summed rest score (SRS) and summed different score
(SDS) were calculated.
Patients were followed up, prospectively for cardiovascular
events 12 months after the CABG: cardiovascular death, myocar-
dial infarction, new onset of angina, stroke, new revascularization
and hospital referral due to episodes of heart failure. Events were
subsequently analysed as primary end points, detected using
available inpatient and outpatient medical records, patient inter-
views and regular cardiac visits. Early (< 30 days) perioperative
events were censored.
SPSS 10 packet for statistical analysis was used. Data are
expressed as mean – SD. Group comparisons were performed
using t-tests for continuous, normally distributed data. P value
£ 0.05 was considered statistically significant. The following vari-
ables were entered into Cox regression models (univariate and
multivariate) to elaborate the factors that determine the postoper-
ative course.
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Results
The male sex was dominant in study population (82.5%
vs. 17.5%). 42.9% of estimated patients were diabetics, 57.1%
had hypertension and 15.9% of patients were obese. Previous
myocardial infarction was detected in 74.6% and history of pervi-
ous revascularization in 15.9% of the study population. Baseline
clinical data is presented in Table 1.
Carotid ultrasound variables
A common carotid artery intima-media thickness mean value
of 0.9 – 0.15 mm was detected. Increased value of CCA IMT
(‡ 0.8) was found in 43 patients (68.3%). In 59 patients (93.7%)
unilateral bulbs plaques were detected and in 42 patients (66.7%)
bilateral carotid plaques were detected.  Population with increased
IMT and carotid plaques was AGED 62.09 – 8.27, with no differ-
ence in mean age of the whole population studied.
Myocardial perfusion findings
Myocardial perfusion Gated SPECT studies showed impor-
tant alterations in both global and regional wall motion and perfu-
sion analysis (Table 2). Mean ejection fraction calculated by this
method was 46.2 – 14.4%. We analyzed a total of 1,071 myocar-
dial segments, of which 720 showed abnormal wall motion (67.2%).
Of these 720 segments, approximately two-thirds (540 segments)
were hypokinetic and one-third (150 segments) were akinetic. Thirty
segments were dyskinetic. Mean viability index was 0.75 – 0.16,
mean SNS 14.89 – 12.19, and mean SRS 19.62 – 14.81.
The average percentage of fixed perfusion defects was 19.13 – 14.09%
of the left ventricular myocardium. Fixed defects were more ex-
tensive in patients with previous myocardial infarction. Patients
with cardiac events during the follow up period showed an aver-
age percentage of fixed defects of 23 – 9%, compared to the
event-free patients, in which the mean percentage of fixed de-
fects was 11 – 7% (p < 0.05). The amount of fixed defects was
higher in patients with cardiac death (28 – 4%). Hibernated myo-
cardium was found in 38 patients (60.3%), with average values
15.72 – 10.48% of left ventricular myocardium. All cardiovascular
caused events were more prevalent in patients with mean viability
index < 0.65.
Tc-99m-Sestamibi demonstrated preserved perfusion, with
perfusion score < 2 in 403 segments (56%) from the 720 dys-
functional segments. The majority of them were severely hypoki-
netic. In the other 317 segments perfusion was severely impaired,
with perfusion scores > 3.
Angiography and coronary surgery
characteristic of population
Coronary disease extension was as follows: single vessel dis-
ease was found in 6 patients (9.5%), double vessel disease
in 22 patients (35%) and triple vessel disease in 34 patients (54.5%).
Calculated mean value of Gensini score was 15.75 – 5.48. Com-
plete revascularization was performed in 52 patients (82%). Left
mammary artery (LIMA) was put in all revascularized patients. There
were 82 arterial grafts and 55 vein grafts implanted. Due to in-
complete revascularization in 11 patients, parts of the viable seg-
ments were probably still left jeopardized.
Cardiovascular events
A total of 14 events were registered in fourteen patients over
one year, with an incidence of 4.5% per patient per year. 6 of them
were fatal cardiovascular events. Among the 8 detected nonfatal
events, 3 were cerebrovascular events, two were episodes of heart
failure, two were new onset of angina and one event was defined
as new revascularization.
When the obtained patients were divided in two subgroups,
patients with events, and patients with no events, a significant
difference was found between the two subgroups in terms of sex
and NYHA classification (Table 3). The presence of plaques,
as well as the value of IMT ‡ 0.8 significantly differs between the
Table 1. Preoperative clinical data
Preoperative clinical data Number of patients (%)
Men 52 (82.5%)
Women 11 (17.5%)
Diabetes mellitus 27 (42.9%)
Hypertension 36 (57.1%)
Previous MI 47 (74.6%)
Obesity 10 (15.9%)
Previous revisualization 10 (15.9%)
Smoking 24 (38.1%)
Family disposition 18 (28.6%)
 MI  myocardial infarction; %  percent of total population evaluated
Table 2. Mean values of myocardial perfusion scintigraphy variables
Variables Average values
LVEF 45.30 – 14.26
Viability index 0.75 – 0.16
Fixed defects (%)  19.13 – 14.09
Viable myocardium (%)  15.75 – 10.48
SRS 19.62 – 14.81
SNS  14.89 – 12.19
 LVEF  left ventricular ejection fraction; SRS  summed rest score; SNS  summed
nitrate score
Table 3. Differences between patients with events vs. without events
Variables Events group No events group p
Categorical
   Male 14/14 38/49 0.05
   EF < 40% 6/14 7/49 0.03
   IMT ‡ 0.8 14/14 29/49   0.002
   Carotid plaque 14/14 28/49 0.01
   Viability index £ 0.55 5/14 1/49   0.001
Continuous
   SNS 20.71 12.02 0.04
   Fixed defects 25.6% 17.2% 0.04
Table presented only variables with significant p between two subgroups. EF  ejection
fraction; IMT  intima-media thickness; SNS  summed nitrate score
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two subgroups. Obtained values of SNS and fixed defects differ
in the two subgroups as well. The most significant difference was
found between the viability index values between the two groups.
Univariate analysis of variables that influence future events,
presented with predictive value: EF < 40 (score = 4.2215,
p = 0.0399), IMT > 0.8 (score = 6.5116, p = 0.0107), VI (score =
= 4.8380, p = 0.0278) and the presence of bilateral carotid plaques
(score = 7.0000, p = 0.0082) were determined. Results of univari-
ate analysis are summarized in table 4, model 1. The presence
of bilateral carotid plaques emerged in the multivariate model, but
did not show any significant value, as shown in Table 5.
Model 2 was built to define predictors of mortality. CCA IMT
by univariate analysis was presented with score = 4.5886, p =
= 0.0322 and viability index with score = 4.3079, p = 0.0379.
These variables: CCA IMT (OR: 2608.6945, p = 0.0265, 95% CI:
2.5016 to 27.2038 105) and viability index (OR: 0.0015, p = 0.0404,
95%: CI: 0.063 10-6 to 0.7525), stepped into the multivariate mo-
del and performed independent predictive values (Table 5). Via-
bility index has been found as a predictor of cardiac events
(OR: 3.471 10-05 95% CI: 7.177 108 to 0.0168), and IMT as a pre-
dictor of cerebrovascular events (OR: 6673.7442, 95% CI: 3.9686
to 1122.2732 104).
Discussion
Preoperative assessment of coronary artery by-pass patients
is not a simple task. There have been many studies addressing
this question and many attempts to build an ideal preoperative
risk model [1215]. Preoperative determination of myocardial via-
bility and left ventricular ejection fraction with myocardial Gated
SPECT has prognostic value for new events, determined by our
studys univariate analysis.
The detection of viable myocardium has become of great cli-
nical importance, due to the major prognostic role and therapeutic
Table 4. Two models of Cox regression analysis of predictors of events/mortality
Model 1 Model 2
Variable Score Sig R  Score Sig R
Prior MI 2.4621 0.1166 0.0631  2.0426 0.1530 0.0293
IMT 3.0089 0.0828 0.0933 4.5886 0.0322 0.2282
HLP 0.0318 0.8584 0.0000 0.4909 0.4835 0.0000
HTA 0.2917 0.5892 0.0000 0.2222 0.6374 0.0000
Diabetes mellitus 1.1667 0.2801 0.0000 1.6806 0.1949 0.0000
Obesity 0.7991 0.3714 0.0000 0.3195 0.5719 0.0000
Fam.disp 0.0000 1.0000 0.0000 1.1321 0.2873 0.0000
EF<40 4.2215 0.0399 0.1384 3.1592 0.0755 0.1527
SRS 2.1884 0.1391 0.0403 1.3157 0.2514 0.0000
Smoking 1.6490 0.1991 0.0000 1.1683 0.2798 0.0000
Carotid plaque (U) 0.0148 0.9031 0.0000 0.4068 0.5236 0.0000
Previous revascularization 0.7991 0.3714 0.0000 0.0028 0.9576 0.0000
IMT ‡ 0.8 6.5116 0.0107 0.1972 2.7907 0.0948 0.1261
VI 4.8380 0.0278 0.1564 4.3079 0.0379 0.2155
SNS 3.2476 0.0715 0.1037 1.0714 0.3006 0.0000
Gensini 0.7019 0.4021 0.0000 0.2778 0.5982 0.0000
Carotid plaque B 7.0000 0.0082 0.2076 3.0000 0.0833 0.1418
Fixed defects 2.1596 0.1417 0.0371 0.7103 0.3993 0.0000
Hiber. myoc 0.0424 0.8368 0.0000 0.0234 0.8785 0.0000
Age 0.1757 0.6751  0.0000 2.8210 0.0930 0.1285
Method: Forward Stepwise (Conditional LR). Model 1 for variables related to total events, Model 2 for variables related to mortality. MI  myocardial infarction; IMT  intima-media
thickness; HLP  hyperlipidaemia; HTA  hypertension; EF  left ventricular ejection fraction; SRS  summed rest score; VI  viability index; SNS  summed nitrate score
 Table 5.  Multivariate analysis of predictors of events/mortality
Variable B S.E.  Wald Sig R Exp (B)
Model 1
   Carotid plaque (b) 3.6483 2.3729 2.3638 0.1242 0.0560 0.0260
Model 2
   IMT 7.8666 3.5458 4.9220 0.0265 0.2424 2608.6945
   VI 6.4902 3.1663 4.2015 0.0404 0.2104 0.0015
Model 1 for variables related to total events, Model 2 for variables related to mortality. Variables IMT and VI are presented by mean value; IMT  intima media thickness;
VI  viability index
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implications of myocardial viability [4]. Clinically it is very impor-
tant to perform proper preoperative patient selection, aimed
at achieving postoperative benefits, left ventricular functional and
clinical improvements [1923]. The functional assessment of hi-
bernation myocardium and the presence of viability are clinically
challenging and have paramount importance for the selection
of the most appropriate individual treatment for patients with chro-
nic severe LV dysfunction [20]. Hibernated myocardium needs
to be revascularized soon after its evaluation, and it needs time
to recover. It is estimated that there is a need of 2530% of viable
jeopardized myocardium before revascularization in order
to achieve post revascularization left ventricular functional recovery.
Revascularization of viable myocardium also decreases the risk
of further LV deterioration and remodelling as well as eliminating
anginal symptoms, diminishing the risk of malignant arrhythmias
and the risk of sudden cardiac death.
Previous studies have demonstrated the prognostic role
of IMT in patients with coronary artery disease who underwent per-
cutaneous revascularization or surgical revascularization [10, 11].
A summary of the relation of IMT and prognosis in pts with CAD
presents CCA IMT with independent relative risk for both coronary
and cerebrovascular events [30].  No previous study has analy-
sed the role of IMT in clinical outcome of pts after coronary surgi-
cal revascularization, or the preoperative predictive value of both
variables: myocardial perfusion imaging findings and common
carotid artery intima-media thickness (CCA IMT) in patients with
coronary artery disease, in relation to mortality rate. According
to our data, the value of IMT for predicting total cardiovascular events
after coronary surgery is small. Using increased IMT ‡ 0.8 mm
as a parameter in univariate analysis facilitates its predictive abil-
ity. Increased IMT indicated a worse outcome in the postrevascu-
larization period. Some authors reported carotid plaques to be
very important for coronary artery disease outcome [1214].
In our study, the predictive value of bilateral carotid plaques was
only presented by univariate analysis. Patients with bilateral carot-
id plaques were significantly more likely to suffer cardiovascular
events compared to patients with unilateral plaque, or without
plaque.
Annual mortality rates in our population were 8.8%. This value
is higher than in randomised studies that evaluated revasculariza-
tion benefits in ischemic heart disease [2426]. Such a high mor-
tality is attributed to a higher prevalence of poor prognostic fac-
tors in our patients compared to other studies, a history of previ-
ous myocardial infarction in 74.6% of patients and significantly
impaired ventricular function in more than a half of them. More
recently reported postoperative mortality rates in highly selected
patients were 6.6%, presumably as a result of advances in the
identification of hibernating myocardium and improvements
in surgical and myocardial protection techniques [16, 22, 23]. Nev-
ertheless, the enthusiasm of surgeons to perform high-risk sur-
gery may dampen unless non-risk stratified surgical results are
used as key performance indicators.
The only variables with independent predictive values for mor-
tality, shown in our multivariate analysis, were IMT and viability
index. In view of our results, our study has confirmed that viability
and survival in revascularized patients is clear and unquestion-
able. The presence of viability alone is not that important, but rather
it is the reperfusion of viable myocardium which matters. Low ejec-
tion fraction is an important marker of risk modelling and is not
a contraindication for surgery, providing that the large areas
of viability are identified, since ejection fraction is a functional pa-
rameter, not simply a number. The average value of viability index
in event free patients in our study was 0.78. Mean VI in patients
with cardiovascular events was 0.71. Our study showed a statisti-
cally significant difference between the percentage of fixed perfu-
sion defects and in patients with and without cardiovascular events.
Viability index has high negative predictive value for cardiovascu-
lar events (NPV 0.15% fold risk for cardiac death). The higher val-
ue of viability index before revascularization predicts better post
revascularization outcome. The importance of assessing viability
with regard to predicting and improving clinical outcome after re-
vascularization was reported by Pagley [27]. A viability index based
on image findings from this study was significantly related
to 3-year event free mortality survival, independent of other variables
including left ventricular ejection fraction. Thus, preoperative as-
sessment of myocardial viability, expressed by viability index
is highly valuable for identifying patients who are more likely to ben-
efit from bypass grafting. Our results showed that patients with
the least amount of viable myocardium and large areas of fibroses
tissue did very poorly in spite of revascularization with 8.8% dying
within one year. A recent meta-analysis found an annual mortality
of 7.7% in revascularized patients with limited viability [28, 29].
There are many studies in the literature dealing with myocar-
dial viability assessment and postoperative recovery of LV func-
tion as well us follow up of the cardiac events [31]. The Allmans
meta-analysis showed that in patients with predominant viability
revascularization was associated with 80% reduction in annual
mortality rate [28]. The decision to revascularize must balance
the risk of myocardial damage and the benefit of revascularizing
hibernated segments [19, 20]. Although now we have the oppor-
tunity to detect viable myocardium with reasonable accuracy, con-
trolled studies of the effects of revisualization of patients with via-
ble myocardium are still a clinical challenge and are quite rare.
Measurement of CCA IMT value responds to coronary patients
own risk factor burden [30]. On our study CCA IMT mean value
CCA IMT is closely related to cerebrovascular events and contrib-
utes significantly to prediction of cardiovascular death in coro-
nary artery bypass patients in the post revascularization interme-
diate period. Therefore it could be suggested as marker for global
cardiovascular risk stratification in these patients.
Study limitations
 This study with one-year follow up does not cover a large
population group. Overestimation of myocardial viability by perfu-
sion scintigraphy could not be excluded. It relates to several fac-
tors: first, scintigraphy may detect islands of vital myocardial cells
of inadequate size to revel left ventricular dysfunction despite suc-
cessful revascularization, or second, functional recovery some-
times takes a longer time if the degree of structural myocardial
changes is very advanced. Observers were not blinded to the
angiographic and myocardial perfusion results. But there was not
any inter-observer disagreement with regard to perfusion image
interpretation and between the cath lab operator and the supervi-
sor of the lab. Using variables as carotid plaque surface or vo-
lume, with 3D ultrasound might be a more sensitive marker for
prognosis. Follow up myocardial perfusion study was not includ-
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ed in our study. We did not find statistically significant early events,
nor was it the goal of our study. We can not exclude graft occlu-
sion as the cause of cardiovascular events in our patients.
Conclusions
Our results indicate that myocardial perfusion viability index
and common carotid artery intima-media thickness are predic-
tors, independently associated with prognosis of patients referred
for CABG, according to this studys newly made model, not
assessed in previous studies. Application of these methods:
carotid ultrasound and myocardial perfusion scintigraphy, has
an important and additional clinical usefulness in the risk assess-
ment approach of coronary artery bypass patients.
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